Q32 Bio Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Q32 Bio Inc. (FIXX) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $57.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-05
- Q32 Bio Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was $2.45M.
- Q32 Bio Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was -$12.48M, a 114.70% decline year-over-year.
- Q32 Bio Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $84.89M.
- Q32 Bio Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$12.49M.
- Q32 Bio Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$29.67M, a 162.66% decline from fiscal 2024.
- Q32 Bio Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $47.35M.
- Q32 Bio Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was -$18.28M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $57.97M 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | $2.45M 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | -$29.67M 10-K · filed 2026-03-10 | |||
| 2025-09-30 | -$28.93M 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | -$23.13M 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | -$12.48M 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | $47.35M 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $58.46M 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $67.04M 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | $84.89M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$18.28M 10-K · filed 2025-03-11 | |||
| 2023-09-30 | -$7.64M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | -$23.84M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$12.49M 10-Q · filed 2024-05-09 |